KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Long-Term Deferred Tax (2022 - 2025)

Acadia Pharmaceuticals has reported Long-Term Deferred Tax over the past 4 years, most recently at $249.9 million for Q4 2025.

  • Quarterly results put Long-Term Deferred Tax at $249.9 million for Q4 2025, up 2772.17% from a year ago — trailing twelve months through Dec 2025 was $249.9 million (up 2772.17% YoY), and the annual figure for FY2025 was $249.9 million, up 2772.17%.
  • Long-Term Deferred Tax for Q4 2025 was $249.9 million at Acadia Pharmaceuticals, up from $8.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for ACAD hit a ceiling of $249.9 million in Q4 2025 and a floor of $1.2 million in Q4 2022.
  • Median Long-Term Deferred Tax over the past 4 years was $7.8 million (2023), compared with a mean of $66.6 million.
  • Biggest five-year swings in Long-Term Deferred Tax: increased 27.94% in 2024 and later soared 2772.17% in 2025.
  • Acadia Pharmaceuticals' Long-Term Deferred Tax stood at $1.2 million in 2022, then skyrocketed by 466.67% to $6.8 million in 2023, then increased by 27.94% to $8.7 million in 2024, then soared by 2772.17% to $249.9 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $249.9 million (Q4 2025), $8.7 million (Q4 2024), and $6.8 million (Q4 2023) per Business Quant data.